Evaluation of Biological Markers of Mesenteric Ischemia During an Ultra-trail

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-06-19

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the evolution of biological markers of mesenteric ischemia during ultratrail.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study Inflammation During a 100 Miles

NCT03256006

Inflammatory Response

UNKNOWN

Problems Associated With Ultramarathon

NCT01602146

Ultramarathon Runner

COMPLETED

Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance

NCT01906203

Healthy Volunteers

COMPLETED NA

the Gut Microbiome and Metabolomics in Chronic Lower extreMities Threatening Ischemia

NCT06220994

Chronic Limb-threatening Ischemia Microtia

UNKNOWN

Assessment of the Increased Risk of Infection Following an Ultratrail

NCT06089174

Running Immune Deficiency Infections

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During physical exercise, increased sympathetic nervous system activity redistributes blood flow from splanchnic organs to working muscles. With prolonged duration and / or intensity, the splanchnic blood flow can be reduced by 80% or more. A severely reduced of splanchnic blood flow can frequently cause gastrointestinal ischemia. This ischemia associated with reduced vagal activity probably results in changes in motility and absorption.

High symptoms are reported in 40% of runners with reflux and heartburn in 15-20% of runners. The low symptoms have an incidence of about 70% in the long runs type ultra-trail.

Biological markers such as I-FABP have been shown to be useful in the diagnosis of mesenteric ischemia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ultra-trail Participation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Runners

To assess the evolution of biological markers of mesenteric ischemia during ultratrail.

Blood analysis

Intervention Type BIOLOGICAL

Blood test of biological markers of mesenteric ischemia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood analysis

Blood test of biological markers of mesenteric ischemia

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy Voluntary Subject
* Age \> 18 years
* Written consent
* Subject affiliated to Social Security
* Medical certificate (mandatory to take part in the ultra-trail)